Inhibition of FLT3-Induced Signalling in Refractory Acute Myeloid Leukemia.

Researchers followed on the efficacy of five FLT3 inhibitors, two pan-PI3K inhibitors, and two c-KIT inhibitors in order to examine the significance of different signaling cascades in FLT3⁺-AML.